These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25278683)

  • 1. Helicobacter pylori infection, gastrin and cyclooxygenase-2 in gastric carcinogenesis.
    Shao Y; Sun K; Xu W; Li XL; Shen H; Sun WH
    World J Gastroenterol; 2014 Sep; 20(36):12860-73. PubMed ID: 25278683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel ZEB1-upregulated protein PRTG induced by Helicobacter pylori infection promotes gastric carcinogenesis through the cGMP/PKG signaling pathway.
    Xiang T; Yuan C; Guo X; Wang H; Cai Q; Xiang Y; Luo W; Liu G
    Cell Death Dis; 2021 Feb; 12(2):150. PubMed ID: 33542225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of cyclooxygenase-2 and microsomal prostaglandin E synthase-1 expression and beta-catenin activation in gastric carcinogenesis in N-methyl-N-nitrosourea-treated K19-C2mE transgenic mice.
    Takasu S; Tsukamoto T; Cao XY; Toyoda T; Hirata A; Ban H; Yamamoto M; Sakai H; Yanai T; Masegi T; Oshima M; Tatematsu M
    Cancer Sci; 2008 Dec; 99(12):2356-64. PubMed ID: 19018769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel role of toll-like receptors in Helicobacter pylori - induced gastric malignancy.
    Uno K; Kato K; Shimosegawa T
    World J Gastroenterol; 2014 May; 20(18):5244-51. PubMed ID: 24833854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifactorial etiology of gastric cancer.
    Zabaleta J
    Methods Mol Biol; 2012; 863():411-35. PubMed ID: 22359309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori-induced YAP1 nuclear translocation promotes gastric carcinogenesis by enhancing IL-1β expression.
    Wu Y; Shen L; Liang X; Li S; Ma L; Zheng L; Li T; Yu H; Chan H; Chen C; Yu J; Jia J
    Cancer Med; 2019 Jul; 8(8):3965-3980. PubMed ID: 31145543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori infection causes gastric cancer? A review of the epidemiological, meta-analytic, and experimental evidence.
    Eslick GD
    World J Gastroenterol; 2006 May; 12(19):2991-9. PubMed ID: 16718777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of Molecular Mechanisms of S-1, Docetaxel and Cisplatin in Gastric Cancer with a History of Helicobacter Pylori Infection.
    Kashani SF; Abedini Z; Darehshouri AF; Jazi K; Bereimipour A; Malekraeisi MA; Javanshir HT; Mahmoodzadeh H; Hadjilooei F
    Mol Biotechnol; 2024 May; 66(5):1303-1313. PubMed ID: 38273052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variations of TLR5 gene interacted with Helicobacter pylori infection among carcinogenesis of gastric cancer.
    Xu T; Fu D; Ren Y; Dai Y; Lin J; Tang L; Ji J
    Oncotarget; 2017 May; 8(19):31016-31022. PubMed ID: 28404962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori infection and gastric cancer biology: tempering a double-edged sword.
    Mentis AA; Boziki M; Grigoriadis N; Papavassiliou AG
    Cell Mol Life Sci; 2019 Jul; 76(13):2477-2486. PubMed ID: 30783683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral microbiota and Helicobacter pylori in gastric carcinogenesis: what do we know and where next?
    Bakhti SZ; Latifi-Navid S
    BMC Microbiol; 2021 Mar; 21(1):71. PubMed ID: 33663382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric cancer: an infectious disease.
    Piazuelo MB; Epplein M; Correa P
    Infect Dis Clin North Am; 2010 Dec; 24(4):853-69, vii. PubMed ID: 20937454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent Tool: Helicobacter pylori Treatment to Reduce the Risk of Both Gastric and Colorectal Cancers.
    Butt J; Epplein M
    J Clin Oncol; 2024 Jun; 42(16):1865-1867. PubMed ID: 38427926
    [No Abstract]   [Full Text] [Related]  

  • 14. Toward Quantification of H pylori-associated Gastric Cancer Risk: Further Evidence Supporting Development of Population-based Strategies for H pylori Eradication.
    Ford AC; Graham DY
    Gastroenterology; 2024 Feb; 166(2):248-249. PubMed ID: 37924852
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular mechanisms of gastric cancer initiation and progression by Helicobacter pylori.
    Servetas SL; Bridge DR; Merrell DS
    Curr Opin Infect Dis; 2016 Jun; 29(3):304-10. PubMed ID: 26779778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diet, H pylori infection and gastric cancer: evidence and controversies.
    Rocco A; Nardone G
    World J Gastroenterol; 2007 Jun; 13(21):2901-12. PubMed ID: 17589938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Mini-review on
    Jacob TV; Doshi GM
    Endocr Metab Immune Disord Drug Targets; 2024; 24(3):277-290. PubMed ID: 37622707
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaccination against Helicobacter pylori - An approach for cancer prevention?
    Friedrich V; Gerhard M
    Mol Aspects Med; 2023 Aug; 92():101183. PubMed ID: 37018869
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Usui Y; Taniyama Y; Endo M; Koyanagi YN; Kasugai Y; Oze I; Ito H; Imoto I; Tanaka T; Tajika M; Niwa Y; Iwasaki Y; Aoi T; Hakozaki N; Takata S; Suzuki K; Terao C; Hatakeyama M; Hirata M; Sugano K; Yoshida T; Kamatani Y; Nakagawa H; Matsuda K; Murakami Y; Spurdle AB; Matsuo K; Momozawa Y
    N Engl J Med; 2023 Mar; 388(13):1181-1190. PubMed ID: 36988593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric cancer: overview.
    Correa P
    Gastroenterol Clin North Am; 2013 Jun; 42(2):211-7. PubMed ID: 23639637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.